Beiersdorf expands Eucerin Dermopurifyer range in Germany

11-Jul-2011 - Last updated on 12-Jul-2011 at 11:14 GMT

Beiersdorf is to expand its Eucerin Dermopurifyer range of skin care products in Germany, specifically targeting acne and blemishes, followed by plans to expand the range in other European countries.

“Acne is one of the most often treated symptoms by dermatologists worldwide. More than 80 per cent of all youths and 40 per cent of all adult females and males are affected by the widest variety of these occurrences”, commented Dr. Simone Presto, medical management Eucerin.

Eucerin has stated that the range can be used for both medical skin care purposes, for those suffering from acne-prone skin, as well as in the form of additional skin care for dermatological patients undergoing medical treatment.

Active ingredients

“Acne-prone skin comes in many varieties, which is why there isn’t just one product that solves the problem for everyone. The symptoms of acne-prone skin require different active ingredients”, explained Stephanie Conzelmann, Eucerin skin research.

As such, the Dermopurifyer range consists of eight different products, which use active ingredient combinations containing lactic acid, l-carnitine, decandiol and licochalcone a.

Clinical studies

Stating that clinical studies were undertaken to test the range, it is claimed that results indicated a significant decrease in acne related symptoms within six weeks.

Drawing a comparison between usage of the range with and without anti-acne medication, Beiersdorf stated results indicated that 78 per cent of patients using the range without anti-acne medication had normalised or improved skin conditions.

However, the use of anti-acne medication together with the dermopurifyer range showed that 81 per cent of patients had normalised or improved skin conditions.

Other results

Other studies conducted have resulted in the following findings, according to the company; high efficacy on all symptoms of mild to moderate acne; an improvement of acne-related quality of life; high rates of product preference and recommendation; and no interference with acne drug therapy.

An international study with 1,033 acne patients (mean age 23.3 years) was conducted over a period of six weeks. It was set up to verify the efficacy, the skin tolerability and the compatibility with medical acne therapeutics.

The Dermopurifyer range

The Dermopurifyer range consists of the following products: